Hearts with hepatitis c: a new hope for transplant patients?

NCT ID NCT04493385

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tracks 500 people who received a heart transplant from a donor with hepatitis C. Researchers want to see if using these organs is safe and works well. They will measure cure rates for hepatitis C, organ rejection, and survival after one year.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

hepatitis C-positive donor heart

What this could lead to

If successful, this could expand the pool of donor hearts available for transplant, reducing wait times for people with heart failure.

What could go wrong

This is an observational study, not a controlled trial, so results may not prove cause and effect. There are risks of hepatitis C transmission, graft rejection, and other post-transplant complications.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEPATITIS C are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

heart failure hepatitis C virus infection

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Baylor Scott & White Health Research Institute

    RECRUITING

    Dallas, Texas, 75246, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••